JORDEN DAVID EMERSON (CIK 1313516) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-31). Recent activity: Buy AURX (789 shares), Buy AURX (7,984 shares), Buy AURX (789 shares), Buy AURX (7,984 shares), Buy AURX (162,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-31 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Buy | 789 | $844 |
| 2026-08-31 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Buy | 7,984 | $8,695 |
| 2026-08-28 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Buy | 789 | $844 |
| 2026-08-28 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Buy | 7,984 | $8,695 |
| 2026-07-02 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Buy | 162,500 | $162,500 |
| 2026-07-02 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Sell | 160,892 | $162,501 |
| 2026-06-05 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Buy | 13,245 | $14,570 |
| 2026-01-05 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Buy | 125,000 | $50,000 |
| 2026-01-05 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Sell | 25,381 | $50,001 |
| 2025-12-03 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Sell | 200,000 | $300,000 |
| 2025-08-04 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Buy | 100,000 | $40,000 |
| 2025-08-04 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Buy | 92,710 | $37,084 |
| 2025-08-04 | Nuo Therapeutics, Inc. (AURX) | CEO/CFO | Sell | 21,313 | $37,085 |
来源：SEC Form 4 申报文件 · 截至 2026-08-31